Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Acrocephalosyndactylia × infigratinib × Clear all

Phase

Status

Withdrawn 1 Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Cholangiocarcinoma 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Liver Neoplasms 1 Colonic Neoplasms 1 Central Nervous System Neoplasms 1 Acrocephalosyndactylia 1

Interventions

lenvatinib 1 infigratinib 1 Rabeprazole 1 E-3810 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04972253 2022-08-10

(BLASST)-3

Dana-Farber Cancer Institute

Phase 1 Withdrawn

Acrocephalosyndactylia, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡